A shadow market for unlicensed slimming drugs is propelled by social media fitness personalities and vendors on messaging platforms, based on new investigations.
Investigational Drug Acquiring Popularity Via Social Media
The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its supposed fat-burning effects. Viewers are encouraged to contact these accounts directly for supplier links, while also receiving promotional offers.
Thriving Trade on Messaging Platforms
Separately, a robust market exists on messaging services, where communities with numerous of participants share “before and after” photos, injection guides and assertions of rapid British shipping. Vendors promote the drug there before directing buyers to other platforms for purchases.
Understanding Retatrutide
This medication is an investigational injection developed by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies suggest it could assist patients lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.
Healthcare Professionals Voice Worries
Nevertheless, physicians and chemists have cautions that the sale of what is still an unlicensed drug in the United Kingdom is worrisome and could lead to users injecting products of unknown origin.
Some experts stated the popularity for the experimental drug could be connected to the rising cost of approved slimming treatments such as Mounjaro.
Legal Position and Implementation
Marketing the unapproved drug on social media or messaging apps is prohibited in the United Kingdom, as it is an unapproved medication that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.
Several content creators attempt to sidestep the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and distribution can still violate medicines, advertising, and customer regulations, risking fines, prosecution or imprisonment.
Service Response and Content Elimination
According to the social media company, the platform has removed problematic material and banned associated hashtags and search suggestions. The organization said it was committed to keeping the service secure and allocating resources in strengthening compliance measures.
Digital Marketplace Operations
Research also found groups with up to 9,000 participants marketing retatrutide using Telegram's built-in discovery tool, which operates like a public directory. Entering “retatrutide” instantly displays groups with numerous of members, populated with images of slimming results, glowing testimonials and detailed guides for mixing or injecting at residence.
After moments of joining one community, a seller shared WhatsApp details, where most transactions occur. The seller sent an instruction manual and promised shipping within two days. When asked whether the substance was genuine, one seller said: “You can’t be sure.” Another shared a image of a supposed testing documentation. None asked about body mass, health issues or past usage.
Product Details and Pricing
Inside these groups, messages display dark colored packages with Royal Mail labels, stating to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, mixed at residence with purified liquid, or pre-filled pens usually priced at £160 for 20 milligrams. When asked how long a pen should be used, sellers give conflicting responses ranging from a several days to “depends on your body”.
Service Moderation and Security Actions
A spokesperson for the messaging service said it actively monitored harmful material on its service including material that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Medical Expert Cautions
“Individuals are administering substances they can’t verify. Even if the research behind this drug is valid, these online products may not include what they advertise,” said Jason Murphy, the director of pharmacy at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to current price rises for approved slimming drugs such as Mounjaro. “With prices rising, individuals are using social media. But counterfeit injections are highly risky. You cannot know what’s contained or whether the environment they were produced in was clean,” she said.
Her staff has previously seen individuals injured by self-injection from unverified suppliers. “We recognize the disappointment, but buying from Telegram or WhatsApp is gambling with your health,” said the doctor. “These materials could be contaminated or incorrectly dosed.”
Manufacturer Statement
A spokesperson from the pharmaceutical company stated the substance was in third stage clinical trials and had not been evaluated or authorized by any government authority anywhere in the world. “Consequently at this time no one can sell [it] for human use,” they explained, adding that any product “falsely representing itself as a company experimental substance not yet approved … may expose users to possibly significant medical dangers”.
